Use of Paediatric Xylometazoline Nasal Drop is not a Child’s Play in Hypertensive Patients on Bisoprolol: A Case Report

(E-pub Ahead of Print)

Author(s): Hira Bhalla*, Abhishek Gupta, Tejas Patel

Journal Name: Current Drug Safety


Become EABM
Become Reviewer
Call for Editor

Abstract:

Xylometazoline, a sympathomimetic agent, is considered safe in hypertensive patients as a relief measure for nasal congestion with intranasal application. In the present case, a 58-year old male patient, having ischemic heart disease, controlled hypertension on telmisartan and bisoprolol, experienced hypertensive urgency in a span of two hours of intranasal administration of the paediatric formulation of xylometazoline. The interaction with bisoprolol should be kept in mind while using xylometazoline.

Keywords: Xylometazoline, sympathomimetic agent, bisoprolol, interaction, hypertensive urgency, intranasal.

Rights & PermissionsPrintExport Cite as

Article Details

Published on: 13 January, 2021
(E-pub Ahead of Print)
DOI: 10.2174/1574886316666210114094856
Price: $95

Article Metrics

PDF: 143